申请人:MIYANAGA Wataru
公开号:US20110082109A1
公开(公告)日:2011-04-07
The present invention provides a pharmaceutical which possesses an excellent inhibitory effect on NHE3 (Na
+
/H
+
exchanger type 3) and effectively improves diseases or conditions of organs in which NHE3 is expressed.
本发明提供了一种药物,具有优异的对NHE3(Na+/H+交换器类型3)的抑制作用,并有效改善NHE3表达的器官的疾病或病况。